tolaini test

Salary:

Highly Competitive Salary

Options All, All, Permanent, Program Manager / Director, United States
Location:

Boston, Massachusetts

Description

ProClinical, in support of our client, are seeking an individual to fill the role of Clinical Trials Manager (CTM), based in Boston, MA.

Reference:

CR.MT.22324_1553011678

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Clinical Practice (GCP), Austria
Location:

Vienna

Description

ProClinical is advertising a vacancy for a Laboratory Quality & Regulatory Manager position

Reference:

22298_1553010383

Salary:

Highly Competitive Salary

Options All, All, Permanent, Director, VP & Physician, United States
Location:

Massachusetts

Description

ProClinical, in support of our client, are seeking a dedicated and experienced individual to fill the role of Senior Director of Medical Science Liaisons, based remotely in the USA.

Reference:

ME.EJ.22197_1553007658

Salary:

Highly Competitive Salary

Options All, All, Permanent, Senior/Director & VP, United States
Location:

New Brunswick, New Jersey

Description

ProClinical, in support of our client, are seeking an individual to fill the role of Medical Writer/Senior Medical Writer, based in New Brunswick, NJ.

Reference:

SC.GW.22303_1553006739

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Ophthalmology, Good Manufacturing Practice (GMP), Germany
Location:

Heidelberg, Baden-Württemberg

Description

ProClinical is advertising a vacancy for a Tech Transfer Manager position

Reference:

QA.TR.22297_1553006171

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), United States
Location:

San Dimas, California

Description

ProClinical is advertising a vacancy for a QA Specialist position

Reference:

QA.SH.22296_1553000503

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), United States
Location:

San Dimas, California

Description

ProClinical is advertising a vacancy for a Quality Manufacturing Specialist position

Reference:

QA.SH.22295_1552999539

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), United States
Location:

San Dimas, California

Description

ProClinical is advertising a vacancy for a Quality Manufacturing Specialist position

Reference:

QA.SH.22294_1552999294

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), United States
Location:

San Dimas, California

Description

ProClinical is advertising a vacancy for a Quality Manufacturing Specialist position

Reference:

QS.SH.22292_1552998815

Salary:

Highly Competitive

Options Pharmaceuticals, Permanent, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), United States
Location:

San Dimas, California

Description

ProClinical is advertising a vacancy for a Quality Manufacturing Specialist position

Reference:

QA.SH.22291_1552997688

The most successful cancer drugs in 2019

As many as 1,688,780 people in the US alone expect to be diagnosed with cancer this year, leading to an unprecedented and skyrocketing demand for better oncology drugs and treatments. Cancer is one of the most feared diagnosis among patients, with over 200 types of the disease as it can affect almost every organ or tissue in the body. Pharmaceutical and biotechnology companies are making incredible strides forward with the development of many innovative and effective treatments for some of the leading causes of death in the world, one of which is lung cancer. Despite increasing cases, survival rates of cancer are improving significantly meaning that cancer is no longer a death sentence for many. ProClinical has compiled the top 10 list of best cancer drugs in 2018, thanks to their outstanding success so far in treating various types of cancer.10. Neulasta$1.11 bnAmgenThis cancer drug has been specifically developed to combat a particular side effect of breast cancer chemotherapy - neutropenia - which is a low count of white blood cells that leaves patients vulnerable to infection. Taken after each cycle of chemo, Neulasta works by stimulating bone marrow to produce more white blood cells which helps the body restore its ability to fight infection. The drug has proven effective in cutting down the duration of severe neutropenia to 1.7 days instead of 5-7 days.9. Ibrance$1.13 bnPfizerIbrance, a targeted biologic therapy used for chemotherapy, has been developed to treat breast cancer - the most common type of cancer. The drug has been approved to use on advanced and secondary cases of breast cancer, and is administered in combination with a hormone therapy. Ibrance works by blocking the effects oestrogen (a female hormone), which stimulates the growth of tumours. This helps slow down the progress of the disease. In November 2018, a phase 3 trial showed that when Ibrance was combined with Faslodex, it significantly extended the lives of patients with advanced breast cancer, suggesting that the drug could soon be used as a new standard of care. 8. Opdivo$1.8 bnBristol Myers SquibbOpdivo is an immuno-therapy that uses a monoclonal antibody to stimulate the body's immune system to kill cancer cells. The drug has been approved to treat a multitude of different cancers, including skin, lung, head and neck, bladder and classical Hodgkin lymphoma. Various studies into the effectiveness of Opdivo on different cancers suggested that it extended the life of 73% of skin cancer patients, 66% of lymphoma patients and 66.5% of bladder cancer patients.7. Imbruvica $2.6 bn Johnson & Johnson/Pharmacyclics Another bestselling oncology drug is tyrosine inhibitor Imbruvica. The drug is used to treat various B cell cancers such as mantle cell lymphoma, chronic lymphocytic leukaemia and Waldenstrӧm’s macroglobulinemia (a type of non-Hodgkin’s lymphoma). According to a recent study, patients being treated with Imbruvica experienced a much better quality of life than those taking similar drugs. The drug also reportedly has a superior adverse event profile and was better tolerated by patients.6. Zytiga$3.5 bnJohnson & JohnsonZytiga is a hormone therapy drug developed to treat prostate cancer, the most prevalent cancer in men. The drug treats patients with prostate cancer that has spread to other parts of the body. As prostate cancer needs testosterone in order to spread, Zytiga works by blocking the enzyme, cytochrome p17, that helps produce it. This causes the tumour to either shrink or slow down. NICE reports that the drug not only extended life but improved quality of life, by reducing pain and improving mental and physical health.5. Keytruda$7.2 bnMerck & CoImmuno-therapy cancer drug, Keytruda, is made up of antibodies that boosts the body's ability to trigger an anti-tumour response that helps it attack cancer cells. It has been approved to treat many types of cancer, including non-small cell lung, classical Hodgkin lymphoma, melanoma, gastric and cervical cancer In 2019, Merck announced plans to fast track the use of Keytruda to treat prostate and head and neck cancer. Trials have shown a 44% reduction in risk of death or the disease worsening with Keytruda. 4. Rituxan $7.6 bn RocheRituxan (rituximab) is just one of Roche’s many cancer biologic success stories. The monoclonal antibody is used to treat many types of blood cancer including non-Hodgkin’s lymphoma and some leukaemias, as well as for other diseases such as rheumatoid arthritis and vasculitis. The antibody works by attaching to B cells that will cause the cell to die (apoptosis). 3. Avastin$7.7 bnRocheMaking the top three cancer drugs in 2018 is Avastin (bevacizumab), taking another spot in Roche’s star portfolio of blockbuster oncology drugs.  The monoclonal antibody drug works by reducing the supply of oxygen and nutrients to a tumour and preventing the growth of new blood vessels. Contributing to its success is its ability to treat a variety of cancers including kidney, cervical, ovarian and brain tumours.2. Herceptin$7.9 bnRocheThe second top selling cancer drug, Herceptin (trastuzumab) another monoclonal antibody developed by Roche. The breast cancer drug is administered via injection and works by attaching itself to HER2 receptors on cancer cells to stop them from growing. Boasting a very high survival rate, Roche is currently looking to improve efficacy further by developing combination drugs. Back in 2017, various biopharmaceutical companies were granted permission to begin making Herceptin biosimilars that are now becoming accessible in large markets worldwide. In 2018, biosimilars Tranzimera (USA) and Ontruzant (Europe) were approved, providing more access for patients to this life-saving drug. 1. Revlimid$9.8 bnCelgeneTop of the best cancer drug list is Celgene's Revlimid (lenalidomide). This drug has been very successful in the treatment of multiple myeloma as it promotes immune responses that slow tumour growth. It is also used to treat myelodysplastic syndromes (MDS). Prior to the development of Revlimid, prognosis for patients diagnosed with multiple myeloma was poor so in the years following the drug’s entry to market, survival rates have soared.ProClinical is proud of the part that it plays in recruiting the skilled oncology professionals that help to develop new life saving cancer therapies. If you are interested in oncology jobs, please upload your CV to enable our specialist recruitment consultants to match your skills and experience with suitable roles.<!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, '2a6fe3dc-c357-4095-b46f-69cb8c58ba43', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Jade Kinsella: From admin assistant to executive board member

Jade Kinsella joined ProClinical in August 2009 as an admin assistant at a time when ProClinical had only six employees. Jade now sits on the executive board as Global Head of Human Resources, overseeing 178 employees across ProClinical’s twelve international offices.With a background in visual merchandising, Jade says she “barely knew what an invoice was” when she assumed her first office-based role at ProClinical! Over the following years, Jade began to shape her career, moving into office management within her first year, expanding into compliance and finance before realising her true talent and passion lay in HR. In 2014, she went on maternity leave following the birth of her first son and studied Human Resource Management (CIPD), returning as the company’s HR Manager. Jade grew the HR function to support the company’s rapid growth internationally, and was promoted to Global Head of HR in early 2018. Jade is an inspiration to many women at ProClinical, having transformed her career to pursue her passion while taking time to enjoy being a mum to her two young sons. Here are her insights into what’s been the key to her success at ProClinical:What drew you to a career in HR?I have always dealt with HR aspects throughout my time at ProClinical and when I looked at the many hats I had worn for the business, HR was the one I had the most passion for. I get a real sense of purpose when I know I have helped solve someone’s problem, both from a personal and professional perspective. I found time to study during my first period of maternity leave, which enabled me to progress fully into Human Resources. Has your progression here taken you beyond your original career aspirations?ProClinical is a company that naturally encourages progression, at all levels. At times where I didn’t have much self-belief, there was always someone in the background here encouraging me to strive for more.  I have had the support of ProClinical’s leadership team since I joined the company and that has continued throughout my career. The journey from a shy girl who didn’t know how to make coffee to a confident woman on ProClinical’s executive board has been challenging but definitely reached beyond my expectations!  What would you put your success down to?I have worked since I was 13 years old and I have always had strong work ethic, no matter which role I have been in. I don’t dwell on negatives for too long which helps me maintain a positive outlook. I have also found that having a reliable nature and being able to find creative solutions has helped me excel, particularly within human resources. I am where I am today because I always strive to better myself for my two children, and want to inspire them to do the same.  What inspiring women have you met in the recruitment industry?I work with extremely intelligent, empowering and successful women every day at ProClinical, who inspire me to be the best version of myself.  Recruitment demands hard work and perseverance, and I really admire women who seek to drive innovation and are happy to have challenging conversations that support change in how a business recruits and supports females transitioning throughout the workforce. In general, I admire both men and women in recruitment who are genuine, authentic, and demonstrate an ability to learn, grow and evolve the industry for the better. What would you say to women looking to succeed in a corporate environment?Believe in yourself. It may not be easy to stand up and express your thoughts and opinions but you’ll be amazed at how empowering, and important it can be. Nothing can prepare you for what might happen, but ensuring you are confident in the way that you deal with situations will get you far. What qualities do you think are important to success?There are many qualities people need to succeed, but I have personally found that two stick out as most important in my experience. 1) Be decisive: people who sit on the fence are not appreciated! 2) Maintain personal and professional integrity: a successful person conducts themselves in a respectable manner and always acts fairly and responsibly. How have you found juggling being a mum whilst continuously growing your career?I have been on maternity leave twice in the past five years and each time I was fully supported by ProClinical, whilst on maternity leave and on my return to work.  Even when I was away I still felt connected to the business, so although it was slightly nerve-wracking returning, after the first day back it was like I never left. Having children has made me feel proud that I can juggle career growth whilst enjoying time with my kids. Being a mum and working full time can be very tough at times, which I don’t think anyone would dispute. However, finding a career you’re passionate about makes it that little bit easier and the rewards by far outweigh the tougher days. Do you have any advice for other working mothers?You can only achieve what you can achieve. Don’t be too hard on yourself - you will get there, even if it takes that little bit longer.  The time I have spent with my little ones by far outweighs anything I have ever achieved professionally. Mostly, remember not to lose faith in yourself. Just because you have taken time out to raise a child, you are still as capable as you were before and when you do return, always strive to be a better version of yourself.ProClinical is delighted to celebrate Jade’s achievements and the many other talented, successful women employed by the company globally. We look forward to seeing our female employees grow in confidence, work together and support each other as they pursue their careers at ProClinical - where the sky is the limit.  If you're a woman in the recruitment industry seeking to join a company that will fully support your career aspirations, consider applying to work for ProClinical. We have a range of junior and senior recruitment consultant jobs available, as well as management and director level positions. Apply today to give your career a boost! <!--[endif]--> <!--[if !supportAnnotations]--> <!--[endif]--><!--[if !supportAnnotations]--><!--[endif]--> <!--[if !supportAnnotations]--> <!--[endif]-->

Read full article

How to progress your med comms career

A career in medical communications is an ideal way for natural communicators to utilise their academic knowledge and expertise to further clinical research and educate the scientific community, healthcare professionals and patients. In a thriving life science industry constantly on the brink of scientific discovery there is plenty of opportunity for med comms professionals to progress their career in new and interesting ways. Whether you work in-house at a life science company or for an agency, medical writers are usually offered on-the-job training or a structured training program. Natural progression means that after the first year you will have begun to establish a varied portfolio of materials, moving into an established medical writer job. However, to progress further and ensure a higher earning potential, there are things that you can do to help define and develop your medical communications career: Consider an agency Working for a med comms agency is a great way to broaden your experience in ways that are not possible working in-house for a single employer. Agency work offers a vibrant, busy environment where you will be exposed to different clients, therapy areas and types of deliverables. Gaining a breadth of experience working with many clients on different projects will help you build up a diverse and varied portfolio, and makes you an attractive prospect for employers as you progress.   Choose the right agency There are many med comms agencies out there but choosing which to work for could dictate the direction in which your career develops. Things to find out during a med comms interviews: What’s the company turnover? This will paint a good picture of whether people enjor working there. This could hint at things like a good work/life balance and attractive employee benefits. These things will help motivate you to work harder. What are the learning and development opportunities like? Try to find out if there is a clear and achievable career progression structure in place. Is there an area of life sciences that the agency focuses on? Find out if their clients represent a range of therapy areas. It’s a good idea not to pigeon-hole yourself by becoming too specialist early on. For more senior roles, you’ll be expected to have good knowledge of multiple therapy areas. What are the types of clients/projects/accounts you’ll get to work on? Try to avoid agencies that are heavily reliant on a small cluster of clients as this will mean much less variety of work, in addition to less job security in the event that they lose an account. Change employers While your company may offer development opportunities, make sure that you take full control of your own career progression. Instead of waiting years for the next promotion, consider moving to another employer to accelerate this progression. Many people are afraid to move too early, worried that this will reflect badly on their resume. However, in the med comms industry there is a high tolerance for changing company/agency, with the average time to move only 2.2 years. Develop your skills Take every opportunity to develop additional skills aside from writing and editing. These skills will be useful in setting you apart from others, helping to speed up your career progression. 1.       Research: Improving your research skills can prove very valuable when presented with an opportunity to take on a new project you have little experience in. Medical writers are expected to provide accurate information on every topic they write about - essentially becoming experts in the subject area. 2.       Mentoring Becoming a mentor to trainees and students is a great way to showcase your potential for a management position. It shows that you’re proactive, knowledgeable and most importantly, a team-player. Becoming invested in other people’s professional development proves that you’ve got what it takes to be a leader. 3.       Project Management: Consider taking courses to develop your project management skills. This experience will give you a boost if you wish to move into a strategic role later on in your career. 4.       Client interaction Take every opportunity to interact with clients so you develop your client management and presentation skills. Experience working with external clients will facilitate your move into high-level client services and strategy roles. 5.       Networking Attend as many industry events as possible to improve your networking skills. As a good communicator, you’ve already got a head start. Learning how to network can help you professionally, by winning business for your company or personally, by helping you find new job opportunities. Join industry groups Becoming a member of industry groups can be really beneficial to your career. Membership grants access to informative newsletters, insight into industry changes, important networking events and even workshops to help expand your knowledge and develop new skills. Example med comms groups to join: European Medical Writers Association (Europe) American Medical Writers Association (USA) If you are interested in getting a medical writer job, or already have a few years’ experience and are looking for your next opportunity, you can apply directly to any of our med comms roles on ProClinical’s job board. Alternatively, you can contact medical communications specialist consultant, George Watson, directly on +1 (336) 842-8682 or via g.watson@proclinical.com for information on available roles that are in line with your skills and experience.  

Read full article

Top 10 new medical technologies of 2019

Technology and medicine have gone hand and hand for many years. Consistent advances in pharmaceuticals and the medical field have saved millions of lives and improved many others. As the years pass by and technology continues to improve, there is no telling what advances will come next. Here are the top 10 new medical technologies in 2019: 10.  Smart inhalers Inhalers are the main treatment option for asthma and if taken correctly, will be effective for 90% of patients. However, in reality, research shows that only about 50% of patients have their condition under control and as many as 94% don’t use inhalers properly.  To help asthma sufferers to better manage their condition, Bluetooth-enabled smart inhalers have been developed. A small device is attached to the inhaler which records the date and time of each dose and whether it was correctly administered. This data is then sent to the patients’ smartphones so they can keep track of and control their condition. Clinical trials showed that using the smart inhaler device used less reliever medicine and had more reliever-free days.  9.  Robotic surgery  Robotic surgery is used in minimally invasive procedures and helps to aid in precision, control and flexibility. During robotic surgery, surgeons can perform very complex procedures that are otherwise either highly difficult or impossible. As the technology improves, it can be combined with augmented reality to allow surgeons to view important additional information about the patient in real time while still operating. While the invention raises concerns that it will eventually replace human surgeons, it is likely to be used only to assist and enhance surgeons’ work in the future. Read more about robotic surgery here.  8.  Wireless brain sensors Thanks to plastics, medical advances have allowed scientists and doctors to team up and create bioresorbable electronics that can be placed in the brain and dissolve when they are no longer needed, according to Plasticstoday.com. This medical device will aid doctors in measuring the temperature and pressure within the brain. Since the sensors are able to dissolve, they reduce the need for additional surgeries. 7.  3-D printing If you haven’t heard, 3-D printers have quickly become one of the hottest technologies on the market. These printers can be used to create implants and even joints to be used during surgery. 3-D-printed prosthetics are increasingly popular as they are entirely bespoke, the digital functionalities enabling them to match an individual’s measurements down to the millimetre. The allows for unprecedently levels of comfort and mobility. The use of printers can create both long lasting and soluble items. For example, 3-D printing can be used to ‘print’ pills that contain multiple drugs, which will help patients with the organisation, timing and monitoring of multiple medications. This is a true example of technology and medicine working together.  6.  Artificial organs To take 3D printing up another notch, bio-printing is also an emerging medical technology. While it was initially ground-breaking to be able to regenerate skin cells for skin draughts for burn victims, this has slowly given way to even more exciting possibilities. Scientist have been able to create blood vessels, synthetic ovaries and even a pancreas. These artificial organs then grow within the patient’s body to replace original faulty one. The ability to supply artificial organs that are not rejected by the body’s immune system could be revolutionary, saving millions of patients that depend on life-saving transplants every year.  5.  Health wearablesThe demand for wearable devices has grown since their introduction in the past few years, since the release of bluetooth in 2000. People today use their phone to track everything from their steps, physical fitness and heartbeat, to their sleeping patterns. The advacement of these wearable technologies is in conjunction with rising chronic diseases like diabetes and cardiovascular disease, and aim to combat these by helping patients to monitor and improve their fitness. In late 2018, Apple made headlines with their ground breaking Apple Series 4 Watch that has an integrated ECG to monitor the wearer's heart rhythms. Within days of its release, customers were raving about the life saving technology, which is able to detect potentially dangerous heart conditions much earlier than usual. The wearable devices market is forecast to reach $67 billion by 2024. 4.  Precision medicine  As medical technology advances it is becoming more and more personalised to individual patients. Precision medicine, for example, allows physicians to select medicines and therapies to treat diseases, such as cancer, based on an individual’s genetic make-up. This personalised medicine is far more effective than other types of treatment as it attacks tumours based on the patient’s specific genes and proteins, causing gene mutations and making it more easily destroyed by the cancer meds.  Precision medicine can also be used to treat rheumatoid arthritis. It uses a similar mechanism of attacking the disease’s vulnerable genes to weaken it and reduce symptoms and joint damage.  3.  Virtual reality   Virtual reality has been around for some time. However, recently, with medical and technological advances, medical students have been able to get close to real life experience using technology. Sophisticated tools help them gain the experience they need by rehearsing procedures and providing a visual understanding of how the human anatomy is connected. The VR devices will also serve as a great aid for patients, helping with diagnosis, treatment plans and to help prepare them for procedures they are facing. It has also proved very useful in patient rehabilitation and recovery. 2.  Telehealth In a technologically driven world, it’s thought that as many as 60% of customers prefer digitally-led services. Telehealth describes a quickly developing technology that allows patients to receive medical care through their digital devices, instead of waiting for face-to-face appointments with their doctor. For example, highly-personalised mobile apps are being developed which allow patients to speak virtually with physicians and other medical professionals to receive instant diagnosis and medical advice. With oversubscribed services, telehealth gives patients different access points to healthcare when and where they need it. It is particularly useful for patients managing chronic conditions as it provides them with consistent, convenient and cost-effective care. The global telemedicine market is expected to be worth $113.1 billion by 2025.  1.  CRISPR   Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is the most advanced gene-editing technology yet. It works by harnessing the natural mechanisms of the immune systems of bacterium cells of invading viruses, which is then able to ‘cut out’ infected DNA strands. This cutting of DNA is what has the power to potentially transform the way we treat disease. By modifying genes, some of the biggest threats to our health, like cancer and HIV, could potentially be overcome in a matter of years.  However, as with all powerful tools there are several controversies surrounding its widespread use, mostly over humanity’s right to ‘play God’ and worries over gene-editing being used to produce hordes of designer babies. CRISPR is still a first-generation tool and its full capabilities are not yet understood.  As the years pass, technology in pharmaceuticals and medicine will continue to improve. People are living longer and fewer diseases are deemed incurable. Jobs in the pharmaceutical industry are in higher demand now than ever. Who knows what the next year will bring in medical advancements! If you’d like to be part of this exciting industry, ProClinical are recruiting for a variety of roles from top pharma, biotech and medical device companies. We would love to hear from you so have a look at our current job opportunities or upload your CV to get started! <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'fea81cfe-036e-4d79-b156-86fa8c1ba666', {}); <!-- end HubSpot Call-to-Action Code --> <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b067d5a2-f614-49b3-add3-d906762f610a', {}); <!-- end HubSpot Call-to-Action Code --> 11

Read full article

Opportunities & challenges for the pharmaceutical industry in 2019

The pharmaceutical industry continues to thrive, yet there are several challenges that may affect the industry's future growth in 2019 and beyond. Drug prices are at an all-time high, R&D productivity has only just begun to climb again following a shortening in 2016/2017 and the pharmaceutical landscape is constantly changing with the rapid growth of biosimilars and disruptions of health technology. As such an important part of our national and global economy, the success of the pharmaceutical industry should be relevant to all. Fortunately, there are many bits of good news in this story, and we’re likely to see the market maintain its current rate of growth for the next five years. Still, in order to thrive in 2019 and beyond, the industry will need to address the following challenges:Slowed market growth The United States is and has led the international pharmaceutical market for many years, so slowed growth here may signal bad news for the global economy. A QuintilesIMS report indicates that market growth in the US will slow to single digits, between 6% and 9%, through 2021, which is down from a 12% growth in 2015. The sluggish market growth is attributed to hepatitis and cancer drugs that are expected to have less of an impact in coming years. Still, the US will remain the world’s largest pharmaceutical market, contributing 53% of all forecasted growth within the next five years. China is expected to continue in the second-largest spot by contributing 12% of the world’s pharmaceutical growth. On a volume basis, the total volume of medicines consumed globally will increase by about 3% annually through 2021, only modestly faster than population and demographic shifts. Issues of pricing, market-access pressures, lower volume growth in emerging markets, and further generic-drug incursion will contribute to the lower rate of growth, according to the analysis. The lull in market growth we are experiencing is to be expected after historically high price increases for pharmaceuticals in recent years. However, the industry will be challenged to find new ways to keep this important industry growing.US drug prices Although President Trump has been in administration for over two years, there is still a major issue over high drug prices in the USA. An example of the current situation: HIV preventative drug, Truvida, has the potential to eventually wipe out HIV if taken by those at high risk of contracting the disease. However, a monthly course costs $2,000 in the US compared to a mere £45 ($58) in the UK, leaving hundreds of thousands of high risk people without access to the drug, and the HIV epidemic allowed to rage on.Mounting pressures by patients, politicians and regulatory bodies over drug pricing and reimbursement led to price freezes in 2018 and a proposal to introduce an 'international pricing index' through Medicare - which would aim to reduce Medicare spending by 30%. The proposal was met widely with criticism due to concerns  and in early 2019 several pharmaceutical companies hiked their prices up even further - an average of 6.3%. The US President faces an ongoing and complex challenge to control increasing drug prices to pave the way or more affordable and accessible healthcare for Americans. The future of biosimilars Biosimilars have made big waves in recent years and there is strong growth predicted across all markets, forecasting over 20% increases over the next five years. However, even though biosimilars are growing at an accelerated rate, the market is still dominated by small molecules with 76% of the market share. Although biosimilars are a growing segment and threaten to take market share from small molecules, there are some challenges to their production. Based on progress to date, the development of biosimilars seems to provide challenges of its own. Despite considerable growth, the market is still in early development and, in some markets, this development is being further slowed by lawsuits over biologic patents. The regulatory processes are not yet solidified either and those that have been developed thus far have required costly clinical trials to gain market approval. Although biosimilars will present competition for biologics, they represent significant savings to the consumer. In the United States, the projected cost savings from switching to biosimilars is expected to be between $40 and $250 billion within the next 10 years. This will go some way in combatting the drug price crisis and make life saving medicines more affordable. Because they are so new to market, biosimilars also present an opportunity for pharmaceutical companies. Those who excel at marketing biosimilars within their product range stand to gain an edge over their competitors. Even pharmas with limited experience of developing biosimilars can grow their portfolios with strategic mergers/acquisitions to increase their capabilities.Patient-centric healthcare Technology trends are driving a shift towards patient-centric healthcare, as evidenced by wearable biometric devices and telemedicine. This trend is resulting in more informed patients who are likely to take a more active role in any treatment plan their doctor may prescribe.   Patient-centric care can provide challenges and rewards for the pharmaceutical industry. The main challenge for 2019 will be determining how to leverage the power of health technology and shifting focus from partnerships with the medical community to partnerships directly with the consumer. In 2019 and beyond, the direct consumer may become the pharmaceutical company’s most strategic partner. When dealing with the consumer, the pharmaceutical company can have an advantage at justifying prices and communicating value. We have seen a shift towards consumerism in recent years with pharmaceutical advertisements, but we can expect this trend to strengthen as drug companies have more opportunity to reach the consumer through wearables and other devices. 2019 will prove to be a crucial year for the pharmaceutical industry to foster a relationship with the public, and a large part of this will rely on their ability to build trust. As with all consumer-based efforts, we can expect that some companies will excel and others will make large blunders. Either way, the rise of consumerism provides an interesting dynamic for competition in this industry. The shift towards value-based healthcare has also forced consumers to look at prescriptions from a new value-benefit lens. Consumers have shown that they want new therapies that are better than anything on the market, and the pharmaceutical companies must have the real-world research to back up such claims. Brexit With the deadline fast approaching for the UK to confirm the terms of their departure from the European Union (EU), the effect of the potential outcomes on the pharmaceutical industry, both in the UK and globally, is not fully known. The fear of a no-deal brexit is causing a sense of panic in the European industry that the UK is working hard to assuage. For example, EU pharmaceutical companies that rely on UK supplies such as Sanofi and Novartis are beginning to stockpile drugs and there are worries over batch testing, blood and organ supply, and changes to regulatory and clinical trial processes which will slow down medicines reaching the UK from the EU post-Brexit. In the face of the unknown, 2019 will be a year of preparing for all possible outcomes. 2019 is proving to be an interesting year for the pharmaceutical industry for many reasons. Slowed market growth, Brexit implications and inflated drug prices are main areas of concern, but we have also seen this in prior years where the market bounced back and adapted to change.   Still, even with its challenges, the pharmaceutical industry is maintaining a stronghold. There is promising news on the horizon with biosimilars and patient-centric healthcare trends that are likely to help the market return to a full thriving state. Emerging markets with strong market growth such as China promise more innovative drug development, hopefully leading to more life-saving drug approvals for patients worldwide. <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b067d5a2-f614-49b3-add3-d906762f610a', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Top 10 pharmaceutical companies to work for according to Glassdoor

Glassdoor is a website where employees from companies across the world can post honest reviews about their employers, in an effort to help prospective employees make an informed decision about where is best to work. ProClinical has used Glassdoor's platform to analyse which are the best pharmaceutical companies to work for, according to honest employee ratings and feedback. <!--more--> In order to qualify for this top pharma employer 10 list, a pharmaceutical company must have over 500 reviews to ensure a more accurate representation of what employees think about the company. On Glassdoor, reviewers are asked to rate the pharma companies out of 5 in the following categories: work/life balance, culture & values, career opportunities, compensation & benefits and senior management. Have a look below to find out which areas the high-scoring pharmaceutical company excel in. They are also rated based on the likelihood that current employees would recommend the company as a place to work to a friend. In cases where companies have the same overall score, those with a higher 'Recommend to a Friend' score have ranked higher on this list. This is because advocacy is a very significant marker in determining the level of employee engagement at a company. Also, potential employees will naturally put more trust in recommendations by current employees to paint an accurate picture of what it's like to work there.   10. Sanofi Glassdoor rating: 3.6Sanofi is a leading French biopharmaceutical company and a staple in ProClinical's top 10 pharmaceutical companies in the world list each year. The company focuses on 7 major therapeutic areas which include oncology, cardiovascular, CNS and vaccines - of which it's subsidiary Sanofi Pasteur is the biggest producer in the world. According to Glassdoor ratings, Sanofi scored highest in the categories of compensation and benefits and work/life balance, and 70% of employees would recommend the company as a place to work to a friend. In 2018, Sanofi was recognised as a 'Top Employer' by the Top Employers Institute for an exemplary employee-centric strategy that provides the company's 110,000 employees worldwide with excellent working conditions. 9. Bristol-Myers Squibb (BMS) Glassdoor rating: 3.6Before the historic merging of Bristol-Myers and Squibb in 1985, each company had a reputation steeped in history dating back to the mid 1800s - including Squibb being a major supplier during the American Civil War. Since joining forces, BMS has gone from strength to strength and has always been a respected and well-liked employer. The company excelled in the Glassdoor categories of compensation and benefits, culture and values and work/life balance and 74% of employees would recommend BMS as a place to work.In 2018 alone, BMS was awarded numerous accolades marking their continued position as a top pharmaceutical employer. Among these was CareerBliss Happiest Companies in America, NAFE Top Companies for Executive Women, Best-of-the-Best Corporations for Inclusion by National Business Inclusion Consortium and Working Mother 100 Best Companies of 2018.8. NovartisGlassdoor rating: 3.7Winning a place on the 2018 Top Employers UK list compiled by the Top Employer’s Institute, Novartis Pharmaceuticals is a well-established global leader in the life sciences industry. The company, based in Switzerland, specialises in many therapeutic areas including oncology, immunology, dermatology and cell and gene therapy. Scoring generally high in all areas, Glassdoor reviewers were particularly impressed with the company’s culture & values and compensation & benefits. Some reviews focused on the dynamic, international working environment, while others praised Novartis’ innovation and dedication to delivering.In 2018, Novartis came 2nd in the Thomas Reuters Diversity and Inclusion Index to acknowledge their dedication to providing equal opportunity to all, regardless of gender, race or sexual orientation. 7. Bayer Glassdoor rating: 3.8 The German pharmaceutical giant, Bayer, has an impressive 150-year history and is famed for developing the drug Aspirin in the late 19th century. The company scored an impressive Glassdoor rating, with 75% of employees willing to recommend the company to a friend. A firm favourite, Bayer was listed as Germany’s top employer in the 2018 ‘Focus’ ranking of employers, as well as achieving 13th place on Glassdoor’s best places to work in Germany. According to over 1,800 Glassdoor reviews, Bayer is a top-scorer in work/life balance and compensation & benefits and also does very well in career opportunities and cultures and values. The reviews include many positive details about the good company structure, supportive management and competitive salaries.6. Eli LillyGlassdoor rating: 3.8Founded 140 years ago in the USA, Eli Lilly is one of the biggest pharmaceutical companies in the world. The company is consistently ranked as an exceptional employer, receiving recognition in a wide range of employer awards. In 2018, these included Top Companies for LGBT Employees, Top 50 Companies for Diversity and Women's Choice Award for Best Places to Work for Millennials and Women. According to over 1,700 Glassdoor reviews, Eli Lilly is commended for its culture & values above all, as well as compensation & benefits and work/life balance.5. AbbVie Glassdoor rating: 3.8Biopharmaceutical company AbbVie employs over 30,000 people worldwide and features each year on the top 10 pharmaceutical companies list. Despite being established very recently in 2013 - following its separation from Abbott Laboratories - AbbVie has quickly become a popular employer. The company scored highly in many categories on Glassdoor - particularly compensation & benefits and culture & values - and an impressive 80% of employees would recommend AbbVie to a friend. The company has been recognised as a leading employer in recent years and won several awards in 2018 alone. Among the most notable accolades was being one of the World's Best Workplaces, a Top 50 Company for Diversity and a Science Top Employer.  4. GlaxoSmithKline (GSK) Glassdoor rating: 3.9 GSK is a global pharmaceutical and vaccine company founded in the UK. A firm favourite with Glassdoor reviewers, GSK has also made it on their list of best places to work in the UK. The company is recognised for its culture and values and work/life balance, suggesting that the company esteems its employee’s happiness and wellbeing very highly. Other GSK Glassdoor reviews spoke highly of training and development and compensation/benefits, and 76% of current employees would recommend GSK as a place to work. An impressive 85% of employees approve of GSK's CEO, Emma Walmsley - the first female CEO to run a top 10 pharmaceutical company.  3. Roche Glassdoor rating: 3.9 One of the largest pharmaceutical companies, Roche Pharmaceuticals is a Swiss company present in over 100 countries. Founded over 100 years ago, the company has grown to be a global leader in several disease areas including infectious diseases, immunology, and cardiovascular and metabolism. Roche comfortably makes it into the top 3, with 80% of employees willing to recommend Roche as an employer and 91% approving of the company’s CEO, Severin Schwan. The reviews praise Roche for its excellent work/life balance and career opportunities, with several suggesting that there is good communication and networking with international colleagues. Already in 2019, Roche Pharma and Roche Diagnostics has been awarded Top Employer in the UK and Europe. In 2018, Roche received recognition as a Science Top Employer, Best Workplaces in Health Care and BioPharma and Glassdoor's 2019 Best Places to Work based entirely on employee feedback. 2. PfizerGlassdoor rating: 3.9Another American biopharmaceutical giant, Pfizer, has earned its place as a global leader thanks to best-selling, world-renowned drugs such as Viagra and Lyrica. The company develops drugs for a broad range of therapeutic areas such as immunology and cardiology. With over 3,200 Glassdoor reviews, Pfizer has come out as a well-rounded employer on Glassdoor, scoring highly in each category.  Particular praise was given in terms of work/life balance and compensation & benefits.Several Glassdoor reviews mentioned excellent international career opportunities and the option to undertake training and development. Glassdoor also shows that 81% of employees would recommend Pfizer as a place to work and 88% approve of the company's CEO, Ian Read.  1. Johnson & Johnson Glassdoor rating: 3.9 Johnson & Johnson take the crown as best pharmaceutical employer according to Glassdoor in 2019. The global pharma company was established in America in 1886 and has since become a steadfast household name thanks to its wealth of well-known consumer goods including Benadryl, Listerine and Neutrogena. J&J has nearly 5,000 employee reviews on the site, by and large celebrating the company for their culture & values, excellent career opportunities and stimulating working environment. In 2018, J&J was named on the list of Best Places to Work for People with Disabilities and won awards for Best Company for Diversity and Best CEOs for Diversity by Comparably. ProClinical is a pharmaceutical recruitment company that is dedicated to helping professionals to find their ideal position working for many of these top pharmaceutical employers. To register your interest, upload your CV and kick start your new search. <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, '2a6fe3dc-c357-4095-b46f-69cb8c58ba43', {}); <!-- end HubSpot Call-to-Action Code --><!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, '2a6fe3dc-c357-4095-b46f-69cb8c58ba43', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Should you make a counter offer to retain a disengaged employee?

Knowing when it’s worth trying to retain employees after they’ve handed in their resignation is a challenge. Life science companies naturally want to do everything to keep their highly-skilled talent. But when it comes to offering disengaged employees retention packages to stay, is it always in the best interest of the employee and the company? When it’s worth it The cost of recruiting someone will undoubtedly be greater than a retention package. Whether it’s a 5k pay rise, a bonus or increased benefits, it makes financial sense to try incentivise an employee to stay. In some situations, the reason for an employee leaving is for a higher salary - so offering a more money could re-spark their engagement once they feel better compensated for their work. If you’re hoping to retain an employee, the best chance at success is to get to the root cause of why they have become disengaged to a point of wanting to leave. If it’s a case of wanting more money - as above - then it may be an easy fix. However, employee disengagement usually runs deeper than dissatisfaction with pay. Other common reasons why employees become disengaged include: Lack of career development/promotion opportunities Bad relationships with manager or teamFeeling undervaluedNot a good working culture fit<!--[if !supportLists]--> With more senior employees or those with specialised/in-demand skill sets it is certainly worth working hard to address these underlying issues to persuade them to stay on. While it’s important to consider the company’s best interests, when negotiating be aware that it is a very personal process for the employee. They’ll be looking for a significant improvement in the quality of their working life and career prospects, so think outside the box when working out a retention strategy. Instead of just offering a pay rise or bonus, ask them about their needs and offer benefits tailored to them. Could they benefit from flexible hours, working remotely a few days a week, childcare vouchers, a company car? A sympathetic, genuine approach to making them happier at the company will go a long way. It could be that both the company and the employee could work harder at progressing their career. For example, the employee may be guilty of not putting their ideas forward enough, but the manager could have tried harder to seek their opinion or involve them in more projects to help develop their career. Suggesting that they move teams or relocate to a different office could resolve any issues with current colleagues and offer better career development opportunities. When it’s not worth it Money is only one incentive and not usually enough to make someone stay long-term. Throwing more money at a situation won’t always help, even if you’re keen to keep them. The employee could always accept the pay rise and leverage it to get an even better deal elsewhere. Beware of employees who are simply playing companies against each other to get an inflated salary. Because of this, some companies refuse to respond to financial counteroffers in fear of setting a precedent. Even if you are offering more than a salary increase, try to be honest about how realistic the retention package is for the employee’s longer-term engagement. Think about how the changes will be implemented and if they will negatively impact the wider team. There may come a point in which it is no longer in the company’s interests to appease an employee who has their foot half way out the door. There is always the issue of how the employee is viewed if they agree to stay on. Will there be any bad feelings towards them by their manager or team? They may be seen as disloyal or less committed to working in the company’s best interests. Their productivity may be questioned. These negative feelings towards them will do nothing to increase their engagement with the company. Sometimes, letting them go with no counter offer is the right thing. It does the employee a favour as they’ll be happier elsewhere and your company can find a more committed and engaged replacement. Even if this is costly in the short-term, it’s made up in the long-term by the increased productivity of an employee who is more compatible with the company’s culture, values and goals.   How to improve staff retention Instead of putting lots of energy and resources into retaining a disengaged employee, invest in systems that will help you to spot signs of disengagement before employees get to this stage. These could include regular performance reviews and frequent employee engagement surveys which give employees a platform on which to express their views, needs and wants. Devising and implementing an employee engagement strategy across the business is worth the effort: if executed well, you’ll see employee engagement and commitment to the company increase and productivity soar. Begin by finding out the current levels of employee engagement in the life sciences industry, and use this as a bench mark to rejuvenate engagement and increase employee retention at your company.   If you decide it’s best to let a disengaged employee go, consider working with ProClinical to help you source a highly-skilled professional who is more in line with the company’s culture and goals. For more information on how to improve staff retention through employee engagement, download our life science engagement report today.  <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b15ab19f-17e0-4d8d-b069-fff2550bd07c', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Should contractors consider relocating abroad for a job?

People these days are hungry for adventure, always looking for new experiences and a better balance between their work and personal life. Living and working abroad is a great way to satisfy the need for new experiences without your career having to suffer. In fact, as a contractor working within life sciences, getting contract jobs abroad are often more beneficial to your career than staying in one place! As a contractor you’re already at an advantage when it comes to relocation. You’re accustomed to change, excellent at adapting to new environments and well-suited to the flexible nature of contract work. Yet, perhaps your contracting career has never taken you particularly far afield so the idea of relocating to a new country is daunting. Like with any big decision, there are some risks attached but also many great opportunities and rewards to enjoy. ProClinical helps hundreds of contractors relocate successfully to pursue great contract jobs abroad, so we’re well versed in the many queries people have about making a big move. In our experience, these are the most important questions to ask yourself when considering contract jobs in another country: It is good timing to relocate for a job? Those looking for long-term contract opportunities abroad and who have spouses and families will have to consider the impact job relocation will have on them. The effects a move will have on a family depends on things like the age of children, the availability of jobs for spouses, the suitability of city itself for their needs etc. While a new start can have many positive effects, just be sure that the pros outweigh the cons. Luckily, if it’s a short-term contract, you could consider moving by yourself and returning to your friends and family when the contract ends. Cross-culture travel and improved communication methods make these sorts of arrangements much more feasible. Often your employer will offer packages that include regular trips home to see loved ones so be sure to explore your options. Another timing consideration is whether it’s a suitable point in your career for a big move. The good news is that for contractors this isn’t really a big issue. The nature of your job means you’re moving around a lot regardless of where you are in your career. However, it’s still worth doing some research to ensure your current skills and experience level can be leveraged in your chosen city/country. What opportunities are available to you abroad? This leads on to considering the opportunities available to you once you move. You may be lucky and have a contract lined up, or maybe not. You might have one contract in the pipeline but no concrete plans after that even though you plan to remain in the new city for longer. Not having these assurances can be daunting. Therefore, before you up sticks and leave, do your research! If you work in biotechnology or medical devices, check that the city and surrounding region have ample opportunities in these industries for you to grow your career. Is there another city that boasts better contracting jobs in biotechnology in the long-term? If you have a specialised skill set, which is common in life sciences, make sure that you choose a city that has demand for your expertise. This way you’ll never be stuck for your next contract if you want to stay in the city. Once you’re sure the location is right, now consider the benefits to your future career. Gaining experience abroad is always an advantage; you learn about different markets, different processes and systems, gain broader perspectives. All of this knowledge can only enhance your career, particularly as a contractor where gaining a competitive advantage will allow you to charge higher rates for your time and expertise. What is the city/country really like to live in? Putting aside considerations about the job and the process of relocating, have you thought about what the city/country will be like outside of work? Whether you are moving to a neighbouring country or another continent entirely, there will likely be cultural differences to adjust to. You might think it doesn’t matter as much if you’re there temporarily on a contract but think about the experiences and opportunities you’ll be missing if you don’t embrace and try to assimilate into the city’s culture. Find out what makes the city or country different; what’s the language? What’s the average cost of living? What are the customs? What is there to do and see in the city? It’s a great way to get yourself excited about the day-to-day experiences and little adventures you’ll have when you’re not working. It will help paint a more complete picture of what your life will be like in a new place. Also important to consider are things like how easy is it to get a visa to live and work, get around the city (transport links) and what the tax system is like. For contractors using an umbrella company, differences with tax will be less of a concern. However, if you operate under your own limited company, moving abroad will likely involve setting up a new company within the new country. While this may be a slight inconvenience to begin with, it’s probably a minor problem in the grand scheme of things when you take into consideration the benefits of moving. These include very competitive rates, career enhancement, new skills and a great relocation package. What could your relocation package be like? This mostly applies to people who already have a contract lined up. As touched on earlier, relocation packages or relocation allowances can make all the difference if you’re on the fence about moving away for a job. Employers understand that relocating can be expensive and that it’s difficult to leave your friends and family. They also known that it’s worth it for the experiences you’ll gain, both professionally and personally. However, employers often offer very attractive relocation packages to ease the transition, giving contractors the little push they need to make the jump. Relocation packages vary widely according to the individual’s needs and the employer, for instance whether you have a family, or the location of the contract. They can include transportation costs like flights, accommodation for an agreed period of time (sometimes throughout the entire contract) and regular trips to your home country to see family and friends. These packages are commonplace for contractors working within the life science industry, but particularly so for contractors working on remediation projects - when locations are a little more remote and the projects more urgent. In these situations, contractors are in for a pretty good deal! If you decide to take the plunge and accept a contract job abroad, you’ll be in for a real experience! Our advice is to make sure you’ve got your ducks in a row and that you are prepared for whatever comes your way. Moving abroad can be challenging at times but the experiences and benefits to your future career are usually well worth it.  Whether we’ve helped bring you closer to a decision or sparked a desire to live and work in another country, get in touch with ProClinical today for more information on contracting jobs abroad. You can also register your interest in working in various countries by filling out this international opportunities form. It could be the career boost you need or the new experiences you’ve been longing to have! <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b067d5a2-f614-49b3-add3-d906762f610a', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Five ways that pharma jobs in Switzerland can benefit your career

Ambitious professionals in the pharmaceutical industry are reaping the benefits of migrating to Switzerland, which is home to many of the world’s biggest pharmaceutical companies. ProClinical's life sciences recruitment specialists have observed five key reasons why candidates who have experience in working in Switzerland are gaining an advantage over their peers. Switzerland has one of the highest rates of foreign workers in Europe, and there is a strong demand for companies in Switzerland to import highly skilled professionals from other countries. According to the business federation, Economiesuisse the free movement of labour into Switzerland is vital to the country’s economic growth and stability. This is particularly true in the pharmaceutical industry, which accounts for 30% of all exportation; however, the workforce is not large enough to support the amount of pharmaceutical companies based there. This affords great opportunities for pharmaceutical professionals in the UK (see end of article for impact of Brexit), Germany, France and other European countries to work in the Swiss pharma industry—an opportunity that should not be underestimated by pharma professionals.Many of the top candidates that ProClinical place have some experience of working in the Switzerland—and that is no coincidence. Take a look at our list of five reasons why working in Switzerland can have long-term benefits for your career.You will gain experience in multiple therapies and marketsEconomic stability, quality of life and relatively low taxation make Switzerland an attractive location for many multinational organisations. Many of the world’s biggest pharmaceutical companies, including Swiss pharma giants Novartis and Roche, as well as non-domestic companies Pfizer, Merck, Sanofi, Biogen, Amgen and Celgene, all have global or regional headquarters in Switzerland. Although there are many global and regional offices outside of Switzerland, the proportion of them is far higher there than in other countries.Switzerland has a strong history of innovation in the pharma industry. There can be a world of difference between the projects being worked on at headquarters and those that are based in other national sites. You are likely to be involved in bigger assignments, including multinational projects that are run centrally from Switzerland. Projects also tend to be more varied; local sites often work on one compound or therapy area but at headquarters there are likely to be several, and teams can be frequently reassigned as required. The result is that you will acquire a diverse set of skills and experience in a relatively short time. It can take other pharma professionals several years of moving to different companies and locations to obtain comparable experience elsewhere. There are more promotion opportunitiesAs in other industries, a shared frustration among many pharma professionals who decide to move jobs is that they were unable to gain promotion with their current employer because of the lack of positions for them to move into. The pharmaceutical industry in Switzerland directly and indirectly employs approximately 200,000 people—almost twice that of the UK—and there is often a more defined corporate structure at head offices, affording you greater opportunities to progress. This is good news for permanent employees looking to climb the career ladder without having to change jobs every few years. Many of the organisation's senior positions will be based within Swiss headquarters, which presents excellent networking opportunities. You will enhance your language and cultural skills Working abroad is never an easy decision to make, especially if you don't speak the local language. Switzerland is a country that is culturally diverse and there are four official languages: French, German, Italian and Romansh. Although you would not necessarily need to be multilingual to work in the pharmaceutical industry in Switzerland, as a foreigner integrating into life in another country it would be advantageous to learn at least one of the local languages. You would be communicating mostly in English at work but you should be prepared to adapt to local customs and have a life outside of work too. Adapting to life in another country can be difficult at first but being able to communicate in other languages and demonstrate experience of working in a diverse environment can significantly enhance your future career prospects. Your CV will stand outEmployers and life sciences recruitment companies typically filter through hundreds of CVs every week to find the best candidates. In the pharma industry, a CV or LinkedIn profile with experience of working in Switzerland, particularly for a top ten pharmaceutical company such as Novartis, Roche, Sanofi or Pfizer, will stand out above most—largely for the reasons mentioned above. As a result, you can expect to be approached by headhunters with very attractive opportunities that will help you to progress your career further. You will increase your salaryEmployers and job-seekers both acknowledge that a change in jobs usually comes with an increase in pay. Salaries in Switzerland are some of the highest in the world, and many people move there because living and working in Switzerland offers a very attractive lifestyle. While many often choose to remain in Switzerland, those who move back home or on to another country can find that they are able to maintain or even increase their salary when they take their next role. Furthermore, your salary can sometimes have a bearing on how employers might perceive your suitability for a role, and in some cases it can subconsciously influence them to offer you a more senior position.A word about the impact of Brexit on pharma jobs in Switzerland...Although Switzerland is not a member of the European Union (EU), Brexit is likely to have some impact in terms of the countries having to renegotiate the Swiss-British relationship. Luckily, the relationship between the two countries has always been strong as each depend on the other heavily for trade and labour. This is particularly true within the life science industry as both countries are within the 'inner circle' of trading partners for chemical, pharmaceutical and med tech products.In terms of free movement of labour between the UK and Switzerland, this will surely continue. Medical technology and pharmaceutical companies in Switzerland currently employ thousands of UK life science professionals, and many SMEs in Switzerland continue to see the UK as an important market. Therefore, professionals who live in the UK thinking of relocating to Switzerland for jobs in pharma should rest assured that future Brexit negotiations will not affect their ability to work in Switzerland. In fact, the Swiss-British relationship is likely to grow in strength and result in more market access, regulatory harmonisation and generally more collaborative effort. ProClinical currently has a number of vacancies at Swiss pharmaceutical companies, as well as biopharmaceutical, medical device and clinical research organisations throughout Switzerland. If you have Swiss pharmaceutical experience or are interested in relocating to Switzerland, please send us your CV or apply to our pharma jobs in Switzerland.  <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b067d5a2-f614-49b3-add3-d906762f610a', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article

Life science companies hiring graduates right now

All too many life science graduates find themselves struggling to bridge the gap between academia and their future career. Finding the right opportunity to kick start their professional development counts for a lot - but it’s often challenging to find. Being trained by a leading life science company is a great option for graduates. It offers a strong start to their career thanks to excellent development programs and the resources available to provide first-class training. Although some graduates may be little late to the party as some deadlines have passed, there are still some great graduate programs and entry-level life science jobs available. Here is just collection of leading pharma, biotech and med device companies hiring graduates right now: GlaxoSmithKline (GSK) GSK is a British pharmaceutical company and has been a staple on ProClinical’s annual top 10 pharmas in the world list. It is also one of the best pharmaceutical companies towork for according to Glassdoor, being recognised for providing excellent training and development opportunities for its employees. GSK’s Future Leaders program is still open for recent life science graduates looking to learn about various aspects of the business and runs over a 2-3 year period. There are several areas available to specialise in for life science graduates, ranging from research and development, manufacturing and supply to business operations and sales and marketing. They even have a handy quiz to help you decide which program you’re most suitable for. If this program isn’t the right fit, GSK also has a host of internships, summer placements, industrial placements and entry-level jobs for life science graduates living in the UK and USA. Johnson and Johnson Currently the most successful life science company in the world, Johnson & Johnson is a multi-national conglomerate with plenty of opportunities to offer new graduates. For those looking for a structuredgraduate scheme, there’s the Experience Leadership Development programs and internships which are available in a range of specialist areas and industries, including medical devices, human resources, technology and finance. These programs are available in multiple locations all over the world, particularly in emerging life science industries like South Korea, Brazil, Indonesia and Thailand. Additionally, there is a number of full-time graduate life sciencejobs available on the Johnson & Johnson job page across the business’ consumer healthcare, pharmaceutical, biotechnology and medical device subsidiaries. These will all appear together if the keyword ‘graduate’ is entered into the search function. Takeda Japanese pharmaceutical company, Takeda, is currently the biggest pharma company in Asia. The company was awarded global Top Employer status in 2018 and is dedicated to creating an environment in which its employees can thrive. Currently, Takeda has a few programs still open for life science graduates. These include the IT Professional Development Program and the MBA Commercial Leadership Program. Aside from these programs, there are also a number of internships and entry-level life science jobs to be found on the Takeda job forum. These opportunities are scattered at various locations including San Diego, a major life science hub on the West Coast of America.   Merck Leading American pharmaceutical company, Merck, is naturally an attractive prospect for graduates looking for a strong start to their career. Dedicated to fostering diverse and promising talent to contribute to their innovative pipeline and catalogue of successful medicines, the company offers great opportunities to life science graduates. Merck’s GoGlobal platform and Functional Graduate program offer recent science grads the chance to undertake up to 3 years of rotations within core business areas. The GoGlobal program is specifically for those with dual degrees in natural science and business, but the Functional Graduate program is far more wide ranging with the option to specialise in areas such as Finance, Supply Chain, Research & Development and Quality, Regulatory and Compliance. Merck’s main job page also has a handy search function “Career Level B - recent university graduate” which automatically brings up graduate programs, internships and entry-level roles suitable for life science graduates across their global offices. Stryker Stryker is one the biggest medical device companies in the world and recent life science grads wanting to kick start their career in medical devices can expect great training and development opportunities here. The company recruits students and recent graduates for its 3-month intern positions and recruitment usually begins at the beginning of the year, ready for a September start. Internships take place across Europe, China, Singapore and as far flung as Australia and New Zealand. Be aware, the bulk of these opportunities are suitable for those currently enrolled in a course. For those wishing to go straight into full-time work, Stryker also offers a number of entry-level medical device jobs on their main job platform. Like the internships, these opportunities are available across Stryker’s various global offices, in locations like Germany, the USA, the Netherlands, Japan and South Africa. AstraZeneca British pharmaceutical giant, AstraZeneca, is an excellent choice as a first employer for graduates looking for a job in pharma. AstraZeneca offer excellent opportunities for recent science graduates, including many graduate programs. While some may already have closed there are still some programs accepting applications, although it’s advisable to act quickly to avoid missing out. For example, the IMED Early Phase Drug Discovery program is still recruiting for places in the UK, USA and Sweden. Other available programs include Biometrics & Statistics, Data Sciences & AI and Human Resources. The company has an entire page dedicated to ‘Early Careers’ and has separate opportunities for students, undergraduates, graduates/masters and postdocs. For more advice on what to do with a life science degree, check out ProClinical’s Career Advice page, where there are several articles aimed at supporting graduates in their early career. There will be advice on CV writing, attending interviews, transferable skills and the different types of jobs and career paths available to life science graduates. Alternatively, there is also option of using a life science background to become a specialist life science recruiter. ProClinical offers an excellent global life science recruitment graduate programme for those who wish to use their expertise in a fulfilling and financially rewarding career.   <!--HubSpot Call-to-Action Code --> hbspt.cta.load(321476, 'b067d5a2-f614-49b3-add3-d906762f610a', {}); <!-- end HubSpot Call-to-Action Code -->

Read full article
close